Back to School, Simplified with Omnipod® 5

Head Back to School with Confidence 

A new school year brings new routines, responsibilities, and independence – whether that’s starting primary school, navigating high school or heading to university. 

For people living with type 1 diabetes – and those that support them – back to school is a great time to explore Omnipod® 5.

No multiple daily injections or finger prick testing‡. Omnipod 5 proactively helps to correct highs and protect from lows1,2 – simplifying your diabetes management.

What is Omnipod® 5?

Omnipod® 5 is Australia’s only tubeless Automated Insulin Delivery (AID) System that works with leading CGM sensor brands.* 
Compatible with Dexcom G6, Dexcom G7 and FreeStyle Libre 2 Plus Sensors, Omnipod 5 automatically adjusts insulin delivery every five minutes based on CGM readings to help keep glucose levels in range1,2. 
For families and users, this can mean: 

  • Fewer disruptions during class, lectures or exams
  • Less reliance on school staff
  • More confidence during sport, camps and travel 
Learn more about Omnipod 5
Omnipod 5 Omnipod 5

Already a Podder? Visit our Back to School Podder Resource Page

Podder Resources

Designed for all Life Stages

Whether you’re a parent supporting a child, a teenager building confidence, or a uni student managing diabetes independently, Omnipod® is designed to fit into your life.

No multiple daily injections, and no tubes: Each tubeless, wearable Pod delivers insulin for up to 3 days (72 hours). Your child or teenager can go to school, cycle, or play with friends with fewer interruptions. 

Waterproof†: The Pod can be worn while swimming, bathing, or showering. 

Discreet: Small enough to be worn under a uniform or everyday clothing, with no tubes hanging loose.

Accurate: Precise dosing with 0.05 unit increments gives you greater control around mealtimes.

Podder, outside on his bike, wearing his Omnipod 5 Podder, outside on his bike, wearing his Omnipod 5

"The school used to supervise the injections, now they’re just watching him tap into his little device"

Angela, mum of a 6-year-old Alex Living with T1D

Go Back to School with confidence with our tools and support

Thumbnail of a video with the word "Hello" against an orange background Thumbnail of a video with the word "Hello" against an orange background

 

Speak to an Omnipod® Specialist

Have more questions about the Omnipod® System? Enter your information below and one of our Omnipod® Specialists will call you in 24-48 hours for a one-to-one chat.

Talk to a specialist
Omnipod Pod Experience Kit box against a transparent background Omnipod Pod Experience Kit box against a transparent background

 

Pod Experience Kit

Not sure if Omnipod® 5 is right for you or your family? The Pod Experience Kit* contains a real-size, real weight demo Pod*, without the insulin. It’s designed to give you an idea of what it feels like to wear a Pod and get a sense of how discreet it can be to fit into school, sport or uni life.

 

Request your FREE Demo Pod
The front page of the Caregiver Guide. Podder, wearing an Omnipod 5 and playing football The front page of the Caregiver Guide. Podder, wearing an Omnipod 5 and playing football

 

Omnipod® 5 Caregiver Guide

Designed to support parents, teachers, school nurses, carers and families, the Omnipod® 5 Caregiver Guide explains the basics of how the system works and helps answer common questions in school and care settings. 

Read the Caregiver Guide

Want to know more about Omnipod?

To learn more about Omnipod 5, check out our library of resources.

‡Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.

*The Demo Pod is a needle-free, non-functioning Pod. It will not deliver insulin. The Pod Experience Kit does not include a physical Controller.

†The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Controller is not waterproof.

1. Brown S. et al. Diabetes Care. 2021;44:1630-1640. Prospective pivotal trial in 240 participants with T1D aged 6 - 70 yrs. Study included a 14-day standard therapy (ST) phase followed by a 3-month Omnipod 5 hybrid closed-loop (HCL) phase. Mean time in range (3.9-10.0 mmol/L or 70- 180mg/dL) in adults/adolescents as measured by CGM: ST = 64.7%, 3-mo Omnipod 5 = 73.9%, P<0.0001. Mean time in range (3.9-10.0 mmol/L or 70-180mg/dL) in children as measured by CGM: ST = 52.5%, 3-mo Omnipod 5 = 68.0%, P<0.0001. Mean time in hyperglycaemic range (>10.0 mmol/L or >180mg/dL) as measured by CGM in adults/adolescents and children ST vs. 3-mo Omnipod 5: 28.9% vs. 22.8%; 44.8% vs 29.7%, P<0.0001, respectively. Mean time in hypoglycaemic range in adults/adolescents (<3.9 mmol/L or <70mg/dL as measured by CGM) as measured by CGM: ST = 1.89%, 3- mo Omnipod 5 = 1.32%, P<0.0001. Mean time in hypoglycaemic range in children (<3.9 mmol/L or <70mg/dL as measured by CGM): ST = 2.21%, 3-mo Omnipod 5 = 1.78%, P<0.0456.

2. Sherr J. et al. Diabetes Care. 2022; 45:1907-1910. Single-arm multicenter clinical trial in 80 pre-school children (aged 2-5.9 yrs) with T1D. Study included a 14-daystandard therapy (ST) phase followed by a 3- month AID phase with Omnipod 5 system. Mean time in range (3.9-10.0 mmol/L or 70- 180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 57.2% vs 68.1%, P<0.0001. Mean time in hyperglycaemic range (>10.0 mmol/L or >180mg/dL) as measured by CGM in children ST vs. 3-mo Omnipod 5: 39.4% vs. 29.5%, P<0.0001, respectively. Mean time in hypoglycaemic range (<3.9mmol/L or <70mg/dL as measured by CGM) ST = 3.43% vs Omnipod 5: 2.46%, P<0.0001.

INS-OHS-01-2026-00130 V1.0